Bank of New York Mellon’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-460,299
| Closed | -$24.6M | – | 4437 |
|
|
2016
Q1 | $24.6M | Sell |
460,299
-220,914
| -32% | -$11.8M | 0.01% | 1280 |
|
|
2015
Q4 | $77M | Buy |
681,213
+212,115
| +45% | +$24M | 0.02% | 654 |
|
|
2015
Q3 | $55.2M | Buy |
469,098
+216,379
| +86% | +$25.5M | 0.02% | 786 |
|
|
2015
Q2 | $19.6M | Sell |
252,719
-334,847
| -57% | -$25.9M | 0.01% | 1498 |
|
|
2015
Q1 | $34M | Sell |
587,566
-461,700
| -44% | -$26.7M | 0.01% | 1117 |
|
|
2014
Q4 | $33.8M | Sell |
1,049,266
-145,686
| -12% | -$4.7M | 0.01% | 1114 |
|
|
2014
Q3 | $29.2M | Buy |
1,194,952
+601,401
| +101% | +$14.7M | 0.01% | 1183 |
|
|
2014
Q2 | $10.5M | Buy |
593,551
+72,541
| +14% | +$1.29M | ﹤0.01% | 1894 |
|
|
2014
Q1 | $10.4M | Buy |
521,010
+326,657
| +168% | +$6.54M | ﹤0.01% | 1882 |
|
|
2013
Q4 | $3.26M | Buy |
194,353
+88
| +0% | +$1.48K | ﹤0.01% | 2564 |
|
|
2013
Q3 | $2.06M | Buy |
194,265
+77,069
| +66% | +$819K | ﹤0.01% | 2836 |
|
|
2013
Q2 | $655K | Buy |
+117,196
| New | +$655K | ﹤0.01% | 3389 |
|